Via Inserm, Aviesan, is a member of the International Consortium for personalised medicine, ICPerMed

ICPerMed was launched at workshops organised by the European Commission.

It includes non-profit public and private bodies for funding health research and the setting up of public policies. ICPerMed wants to contribute to the implementation of personalised medicine for the benefit of patients, citizens and society as a whole and to facilitate the coordination of research and financing activities, first at European level then at international level. The FPGM 2025 takes part in working groups dedicated to “health economics, regulation and market access” aspects and “data and information and communication technology”;